Italian Government Defies Court Ruling, Lists CBD as Narcotic

Jul.15.2024
Italian Government Defies Court Ruling, Lists CBD as Narcotic
Italy defies EU law, listing CBD as narcotic. Italy's move sparks backlash from hemp industry, threatens 10,000 jobs.

According to a report from Hemptoday on July 12, the Italian government has ignored a ruling from a regional administrative court and violated EU law by placing CBD on the country's list of narcotic drugs.


The Italian Ministry of Health stated that this regulation complies with Italian Presidential Decree 309/1990, which forms the cornerstone of Italy's drug legislation. However, this contradicts a ruling from a regional court last year, which was based on legally binding judgments within the European Union.


This is the latest move by the Italian government against CBD. In October 2020, the Ministry of Health classified CBD as a narcotic drug for the first time and banned it from the market, but soon after revoked the order.


In another attempt in early 2022, the national-regional conference updated the language in the 2018 regulation, officially categorizing marijuana as a medicinal plant.


In that scenario, four major cannabis associations filed a lawsuit and the Lazio Regional Administrative Court overturned the regulation a year later, ruling that it violated European law. The European Commission announced in 2020 that CBD is not a narcotic drug and can be legally traded between member states. This decision was based on a landmark ruling by the European Court of Justice the same year.


The Italian Farmers' Association, Cia-Agricoltori Italiani, criticized the government in a statement for not consulting producers before listing CBD as a dangerous drug, stating that this move "has insulted farmers who have invested money and work in the industrial hemp supply chain in recent years".


The farmer's organization stated that


This is not only a controversial measure from legal, health, and scientific perspectives, but also an intervention that could potentially make the already heavily strained supply chain even more complicated.


According to CIA-Agricoltori Italiani, these prejudices are further reflected in a current amendment in the Italian parliament, which aims to ban CBD and all other products derived from hemp flowers.


The group's chairman, Cristiano Fini, stated that


We are facing potential ideological interference that could paralyze a high-value-added supply chain that attracts young people. This supply chain has huge production potential in cosmetics, herbs, green construction, floriculture, and textiles, with an annual turnover of 500 million euros and providing over 10,000 jobs.


Currently circulating in parliament is a proposed amendment that would completely ban cannabis flowers, affecting various aspects of production and trade. The leading cannabis industry organization, Federcanapa, has expressed that the provisions would effectively shut down the sub-industry of cannabis extracts, affecting the use of CBD and other non-psychoactive cannabinoids in herbal remedies, cosmetics, and dietary supplements.


Some lawmakers and other experts have stated that the amendment would result in the closure of 3,000 businesses and the unemployment of 15,000 workers.


Finney stated that Cia-Agricoltori Italiani has invited government representatives to discuss with CBD operators.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ripon Shop Fined After Selling Illegal High-Nicotine Vapes Equal to “50 Packs”in the UK
Ripon Shop Fined After Selling Illegal High-Nicotine Vapes Equal to “50 Packs”in the UK
A Ripon retailer and its director were prosecuted after trading standards officers uncovered hundreds of illegal disposable vapes with nicotine volumes far above U.K. limits. Barlick Megatronic Mobiles Ltd (trading as Phonefix) and director Humayoun Khan pleaded guilty at York Magistrates’ Court on Sept. 4, 2025. Officers seized 654 illegal vapes in February 2024, then bought another unlawful device during an October follow-up. While the dissolved company avoided a corporate penalty, Khan was fi
Sep.08
Tamarind Intelligence: Regulation Will Determine Whether New Nicotine Products Achieve Their Potential
Tamarind Intelligence: Regulation Will Determine Whether New Nicotine Products Achieve Their Potential
At InterTabac 2025, Pablo Cano Trilla of Tamarind Intelligence highlighted the $80 billion global nicotine market, with e-cigarettes leading in North America and heated tobacco in EMEA. He stressed that regulations, bans, and stricter enforcement will shape the industry's growth and improve its image.
Sep.19
Iowa E-Cigarette Law Challenged: Industry Claims New Rules Will Destroy the Industry and Violate FDA Enforcement Discretion
Iowa E-Cigarette Law Challenged: Industry Claims New Rules Will Destroy the Industry and Violate FDA Enforcement Discretion
E-cigarette sellers and buyers asked the Eighth Circuit Court to keep blocking Iowa's HF 2677 bill. The bill would make all e-cigarettes sold in Iowa get FDA approval. They say the federal Food, Drug, and Cosmetic Act blocks this law, as it steps on FDA's toes by adding penalties where FDA didn't act. If the bill goes through, businesses might close and people could lose tools to quit smoking.
Aug.28 by 2FIRSTS.ai
Singapore rolls out red vape disposal bins: Ong Ye Kung says move protects youth and avoids criminal records
Singapore rolls out red vape disposal bins: Ong Ye Kung says move protects youth and avoids criminal records
Singapore Health Minister Ong Ye Kung explained that the islandwide rollout of red vape disposal bins is meant to let offenders—especially the roughly 30% of users under 30—surrender their devices without penalties, avoiding criminal records under the Misuse of Drugs Act. At the same time, the government has imposed tougher penalties on etomidate-laced “Kpods” (including mandatory minimum jail terms and caning) to choke off the supply chain. Authorities will review the effectiveness of the curre
Sep.08
Philip Morris South Africa calls for science-based tobacco regulation, emphasizing a "risk-proportionate" framework to accelerate smoking rate reduction
Philip Morris South Africa calls for science-based tobacco regulation, emphasizing a "risk-proportionate" framework to accelerate smoking rate reduction
Philip Morris International (PMI) South Africa calls for scientific regulation of e-cigarettes to promote tobacco harm reduction.
Aug.29 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai